Giant Cell Arteritis Therapeutics Market to Reach USD 1.63 Billion by 2030
Giant Cell Arteritis Therapeutics Market is expected to reach USD 1.63 Bn. at a CAGR of 6 % during the forecast period 2030.
Giant Cell Arteritis Therapeutics Market Overview :
The Giant Cell Arteritis (GCA) therapeutics market size was valued at approximately USD 1.08 billion in 2023 and is projected to reach USD 1.63 billion by 2030, growing at a CAGR of 6% during the forecast period. GCA is a granulomatous medium and large-vessel vasculitis, predominantly affecting individuals over 50 years of age, with a higher incidence in women and populations of northern European descent. The increasing prevalence of GCA, coupled with advancements in targeted therapies, is driving market growth.
The introduction of biologics, such as tocilizumab (Actemra), an interleukin-6 receptor antagonist, has revolutionized GCA treatment by offering alternatives to traditional glucocorticoid therapy. These targeted therapies not only improve patient outcomes but also reduce the side effects associated with long-term steroid use. The growing awareness and adoption of such advanced treatments are expected to further propel market expansion.
Ask for Sample to Know US Tariff Impacts on Market @https://www.maximizemarketresearch.com/request-sample/86445/
Regional Insights: A Global Perspective
Regionally, North America holds a significant share of the GCA therapeutics market, attributed to the presence of major pharmaceutical companies, advanced healthcare infrastructure, and high consumer awareness. Europe follows closely, with increasing adoption of innovative therapies and supportive regulatory frameworks.
The Asia-Pacific region is projected to exhibit the highest growth rate during the forecast period, driven by factors such as a large aging population, rising healthcare expenditures, and growing awareness of GCA and its treatment options. Countries like India, China, and Japan are emerging as key markets, with domestic companies investing in GCA therapeutics production to cater to local and international demand.
Request a Sample of the US Tariff Impact Analysis Report:https://www.maximizemarketresearch.com/request-sample/86445/
Segmenting the Giant Cell Arteritis Therapeutics Market:
by Therapeutics
Prednisone
Methotrexate
Tocilizumab
Aspirin
Due to their effectiveness in treating patients, tocilizumab and other medications dominated the GCA market. A humanized monoclonal antibody called tocilizumab (TOC) binds to the alpha chain of the human IL-6 receptor to block IL-6 signaling. For patients with giant cell arteritis (GCA), Genentech received FDA approval for a single-dose autoinjector containing tocilizumab (Actemra).
by Route of Administration
Oral
Intravenous
Subcutaneous
Others
by Mechanism of Action
Corticosteroids
Immunosuppressive Agents
Anticoagulants
Others
Want a glimpse inside? Get your sample copy of the report:https://www.maximizemarketresearch.com/request-sample/86445/
Key Players :
1. Sanofi
2. Kiniksa Pharmaceuticals, Ltd.
3. Regeneron
4. GlaxoSmithKline plc
5. F. Hoffmann-La Roche Ltd.
6. Novartis AG
7. AbbVie, Inc.
8. Bristol-Myers Squibb Company
9. Abbott
10. Johnson & Johnson Services, Inc.
11. Johns Hopkins Hospital
12. Fortis Healthcare
13. American College of Rheumatology
14. Duke University Health System
15. Lahey Clinic Foundation
Seeking deep market knowledge? The summary offers critical insights:https://www.maximizemarketresearch.com/market-report/global-giant-cell-arteritis-therapeutics-market/86445/
Critical Questions & Key Findings
- What is the growth trajectory for the Giant Cell Arteritis Therapeutics Market?
- Which factors will drive market expansion in the coming years?
- What are the most promising opportunities and emerging trends in this industry?
- Who are the primary players, and what are their competitive strengths?
These critical questions, among others, are thoroughly addressed, along with projections of CAGR, market segmentation, and revenue streams. This report doesn’t just reveal the current market landscape but also serves as a strategic tool to anticipate market shifts.
Stay in the loop with Maximize Market Research’s most talked-about findings:
Inhalable Drug Market
Global Healthcare Quality Management Market
Why Choose Maximize Market Research?
With our diverse team of experts across various sectors—including technology, medical devices, pharmaceuticals, automotive, and more—MMR provides trusted, industry-verified market research and consulting services. From trend analysis to competitor benchmarking, our goal is to empower businesses to make informed, forward-thinking decisions.
Contact Us Today for Unmatched Market Insights
Maximize Market Research Pvt. Ltd.
3rd Floor, Navale IT Park, Phase 2
Pune Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India
Email: sales@maximizemarketresearch.com
Phone: +91 9607365656
What's Your Reaction?
